HopeStage
Back to all studies
RecruitingNCT06399263

Psilocybin-assisted therapy for young adults with anorexia

About this titleRead the official source — NCT06399263
Medication studyAges 18–25United StatesEating disorders
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 25 years.

Listed locations
San Francisco and 1 more locationSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: November 18, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
40
Sponsor
Marissa Raymond-Flesch, MD, MPH
Sponsor type
Individual investigator
Study type
Drug
Intervention type
Psychotherapy / behavioral intervention, Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 25 Years
Official registry ID
NCT06399263
Official title
Show the full official title

Study of Psilocybin for Anorexia in Young Adults

Recruitment & locations

Recruiting

San Francisco

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Marissa Raymond-Flesch, MD, MPH.

Does this study involve medication?

Yes. The study involves medication, including Psilocybin.

Who can participate?

Listed age limits: 18 years to 25 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies